Literature DB >> 23395966

Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.

Suvarna Shenvi1, Krishna Kumar, Kaushik S Hatti, K Rijesh, Latha Diwakar, G Chandrasekara Reddy.   

Abstract

2,4,5-Trimethoxy chalcones and analogues were synthesized from asaronaldehyde derived from β-asarone. These novel compounds when tested against three human tumour cell lines (MCF-7, SW-982 and HeLa) using MTT assay, revealed that chalcones possessing electron donor groups in para position to carbonyl moiety of phenyl ring A, showed better inhibitory activity (2, 3, 4, 6, 7, 10, 17). When evaluated for antioxidant activities, compound 15 exhibited better free radical scavenging property in DPPH assay while compounds 2, 3, 5, 7, 9, 10, 11, 16, and 18 showed significant NO scavenging activity. All compounds exhibited very good phenyl hydrazine induced haemolysis of erythrocytes in phenylhydrazine assay. Structure-activity relationship (SAR) study using in-silico analysis matched well with in-vitro tumour cell inhibitory activity.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395966     DOI: 10.1016/j.ejmech.2013.01.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  16 in total

1.  Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.

Authors:  Magda F Mohamed; Farid M Sroor; Nada S Ibrahim; Ghada S Salem; Hadeer H El-Sayed; Marwa M Mahmoud; Menna-Allah M Wagdy; Amina M Ahmed; Aya-Allah T Mahmoud; Somia S Ibrahim; Mariam M Ismail; Sanaa Mohy Eldin; Fatma M Saleh; Hamdi M Hassaneen; Ismail A Abdelhamid
Journal:  Invest New Drugs       Date:  2020-08-28       Impact factor: 3.850

2.  (2E)-1-(3,5-Di-hydroxy-phen-yl)-3-(4-meth-oxy-phen-yl)prop-2-en-1-one.

Authors:  K S Ezhilarasi; D Reuben Jonathan; Shanmugam Sathya; K Prathebha; G Usha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-04-26

3.  Nitro Derivatives of Naturally Occurring β -Asarone and Their Anticancer Activity.

Authors:  Suvarna Shenvi; Latha Diwakar; G Chandrasekara Reddy
Journal:  Int J Med Chem       Date:  2014-10-01

4.  Synthetic chalcones with potent antioxidant ability on H₂O₂-induced apoptosis in PC12 cells.

Authors:  Jian-Zhang Wu; Chan-Chan Cheng; Lai-Lai Shen; Zhan-Kun Wang; Shou-Biao Wu; Wu-Lan Li; Su-Hua Chen; Rong-Ping Zhou; Pei-Hong Qiu
Journal:  Int J Mol Sci       Date:  2014-10-14       Impact factor: 5.923

5.  Crystal structure of (E)-2-[(2-bromopyridin-3-yl)methyl-idene]-6-meth-oxy-3,4-di-hydro-naphthalen-1(2H)-one and 3-[(E)-(6-meth-oxy-1-oxo-1,2,3,4-tetra-hydro-naphthalen-2-ylidene)meth-yl]pyridin-2(1H)-one.

Authors:  Sarah K Zingales; Morgan E Moore; Andrew D Goetz; Clifford W Padgett
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-06-14

6.  Chalcone-Induced Apoptosis through Caspase-Dependent Intrinsic Pathways in Human Hepatocellular Carcinoma Cells.

Authors:  Rodrigo Ramirez-Tagle; Carlos A Escobar; Valentina Romero; Ignacio Montorfano; Ricardo Armisén; Vincenzo Borgna; Emanuel Jeldes; Luis Pizarro; Felipe Simon; Cesar Echeverria
Journal:  Int J Mol Sci       Date:  2016-02-22       Impact factor: 5.923

7.  Crystal structures of three 1-[4-(4-bromo-but-oxy)-phen-yl] chalcone derivatives: (E)-1-[4-(4-bromo-but-oxy)-phen-yl]-3-phenyl-prop-2-en-1-one, (E)-1-[4-(4-bromo-but-oxy)-phen-yl]-3-(4-meth-oxy-phen-yl)prop-2-en-1-one and (E)-1-[4-(4-bromo-but-oxy)-phen-yl]-3-(3,4-di-meth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Gunasekaran Maragatham; Sivasamy Selvarani; Perumal Rajakumar; Srinivasakannan Lakshmi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-07-21

8.  (E)-1-(3,5-Di-meth-oxy-phen-yl)-3-(3-meth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Seunghyun Ahn; Ha-Jin Lee; Yoongho Lim; Dongsoo Koh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-05

9.  (E)-1-(1-Hy-droxy-naphthalen-2-yl)-3-(2,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Dongsoo Koh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-03-16

10.  (E)-1-(2-Amino-phen-yl)-3-(thio-phen-2-yl)prop-2-en-1-one.

Authors:  Suchada Chantrapromma; Pumsak Ruanwas; Nawong Boonnak; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.